Cargando…

Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy

BACKGROUND: The composition of venom extracts, cross‐reactive carbohydrate determinants (CCD) and the component‐resolved diagnostics (CRD) are important fields of investigation. IgE‐reactivity to CCD complicates the interpretation of IgE to Hymenoptera venoms, especially in patients with multiple‐po...

Descripción completa

Detalles Bibliográficos
Autores principales: Jovanovic, Dragana, Peric‐Popadic, Aleksandra, Djuric, Vojislav, Stojanovic, Maja, Lekic, Branislav, Milicevic, Ognjen, Bonaci‐Nikolic, Branka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993137/
https://www.ncbi.nlm.nih.gov/pubmed/36973962
http://dx.doi.org/10.1002/clt2.12230
_version_ 1784902469221875712
author Jovanovic, Dragana
Peric‐Popadic, Aleksandra
Djuric, Vojislav
Stojanovic, Maja
Lekic, Branislav
Milicevic, Ognjen
Bonaci‐Nikolic, Branka
author_facet Jovanovic, Dragana
Peric‐Popadic, Aleksandra
Djuric, Vojislav
Stojanovic, Maja
Lekic, Branislav
Milicevic, Ognjen
Bonaci‐Nikolic, Branka
author_sort Jovanovic, Dragana
collection PubMed
description BACKGROUND: The composition of venom extracts, cross‐reactive carbohydrate determinants (CCD) and the component‐resolved diagnostics (CRD) are important fields of investigation. IgE‐reactivity to CCD complicates the interpretation of IgE to Hymenoptera venoms, especially in patients with multiple‐positivity. We analyzed the clinical importance of CRD and CCD‐inhibition for selection of allergens for venom immunotherapy (VIT). METHODS: In 71 patients, we measured specific IgE (sIgE) to honeybee venom (HBV), wasp venom (WV), hornet venom (HV), CCD, and recombinant allergens: phospholipase A2 (rApi m 1), hyaluronidase (rApi m 2), icarapin (rApi m 10), antigen 5 (rVes v 5), and phospholipase A1 (Immunoblot). In 29/71 HBV/WV/HV/CCD‐positive patients CCD‐inhibition was performed. According to CRD and CCD‐inhibition, we identified true sensitization and defined groups of multiple‐positive patients who needed CCD‐inhibition before starting VIT. RESULTS: sIgE‐rApi m 1, sIgE‐rApi m 2, and sIgE‐rApi m 10 were detected in 65.7%, 68.4%, and 58%, respectively. In HBV allergic patients, CRD sensitivity was 86.8%. In WV allergic patients, sensitivity of sIgE‐rVes v 5 was 94%. True multiple‐sensitization was found in 44.8% of HBV/WV/HV/CCD‐positive patients after CCD‐inhibition. Patients with multiple venom‐ and CCD‐positivity had more frequent severe allergic reactions (p < 0.001). CCD‐inhibition was helpful in HBV/WV/HV/CCD‐positive patients who were negative to all tested recombinant honeybee allergens. Persistence of HBV‐positivity after CCD‐inhibition requires CRD to other honeybee recombinant allergens. CONCLUSION: CRD, using a profile of five most important recombinant allergens and CCD, has a high sensitivity for the diagnosis of venom allergy, especially in patients positive to several venom extracts. CRD and CCD‐inhibition are helpful to reveal the clinically relevant, true sensitization and improve the selection of venoms for long‐lasting VIT.
format Online
Article
Text
id pubmed-9993137
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99931372023-03-09 Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy Jovanovic, Dragana Peric‐Popadic, Aleksandra Djuric, Vojislav Stojanovic, Maja Lekic, Branislav Milicevic, Ognjen Bonaci‐Nikolic, Branka Clin Transl Allergy Original Article BACKGROUND: The composition of venom extracts, cross‐reactive carbohydrate determinants (CCD) and the component‐resolved diagnostics (CRD) are important fields of investigation. IgE‐reactivity to CCD complicates the interpretation of IgE to Hymenoptera venoms, especially in patients with multiple‐positivity. We analyzed the clinical importance of CRD and CCD‐inhibition for selection of allergens for venom immunotherapy (VIT). METHODS: In 71 patients, we measured specific IgE (sIgE) to honeybee venom (HBV), wasp venom (WV), hornet venom (HV), CCD, and recombinant allergens: phospholipase A2 (rApi m 1), hyaluronidase (rApi m 2), icarapin (rApi m 10), antigen 5 (rVes v 5), and phospholipase A1 (Immunoblot). In 29/71 HBV/WV/HV/CCD‐positive patients CCD‐inhibition was performed. According to CRD and CCD‐inhibition, we identified true sensitization and defined groups of multiple‐positive patients who needed CCD‐inhibition before starting VIT. RESULTS: sIgE‐rApi m 1, sIgE‐rApi m 2, and sIgE‐rApi m 10 were detected in 65.7%, 68.4%, and 58%, respectively. In HBV allergic patients, CRD sensitivity was 86.8%. In WV allergic patients, sensitivity of sIgE‐rVes v 5 was 94%. True multiple‐sensitization was found in 44.8% of HBV/WV/HV/CCD‐positive patients after CCD‐inhibition. Patients with multiple venom‐ and CCD‐positivity had more frequent severe allergic reactions (p < 0.001). CCD‐inhibition was helpful in HBV/WV/HV/CCD‐positive patients who were negative to all tested recombinant honeybee allergens. Persistence of HBV‐positivity after CCD‐inhibition requires CRD to other honeybee recombinant allergens. CONCLUSION: CRD, using a profile of five most important recombinant allergens and CCD, has a high sensitivity for the diagnosis of venom allergy, especially in patients positive to several venom extracts. CRD and CCD‐inhibition are helpful to reveal the clinically relevant, true sensitization and improve the selection of venoms for long‐lasting VIT. John Wiley and Sons Inc. 2023-03-08 /pmc/articles/PMC9993137/ /pubmed/36973962 http://dx.doi.org/10.1002/clt2.12230 Text en © 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jovanovic, Dragana
Peric‐Popadic, Aleksandra
Djuric, Vojislav
Stojanovic, Maja
Lekic, Branislav
Milicevic, Ognjen
Bonaci‐Nikolic, Branka
Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
title Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
title_full Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
title_fullStr Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
title_full_unstemmed Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
title_short Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
title_sort molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in hymenoptera venom allergy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993137/
https://www.ncbi.nlm.nih.gov/pubmed/36973962
http://dx.doi.org/10.1002/clt2.12230
work_keys_str_mv AT jovanovicdragana moleculardiagnosticsandinhibitionofcrossreactivecarbohydratedeterminantsinhymenopteravenomallergy
AT pericpopadicaleksandra moleculardiagnosticsandinhibitionofcrossreactivecarbohydratedeterminantsinhymenopteravenomallergy
AT djuricvojislav moleculardiagnosticsandinhibitionofcrossreactivecarbohydratedeterminantsinhymenopteravenomallergy
AT stojanovicmaja moleculardiagnosticsandinhibitionofcrossreactivecarbohydratedeterminantsinhymenopteravenomallergy
AT lekicbranislav moleculardiagnosticsandinhibitionofcrossreactivecarbohydratedeterminantsinhymenopteravenomallergy
AT milicevicognjen moleculardiagnosticsandinhibitionofcrossreactivecarbohydratedeterminantsinhymenopteravenomallergy
AT bonacinikolicbranka moleculardiagnosticsandinhibitionofcrossreactivecarbohydratedeterminantsinhymenopteravenomallergy